JND3229 is utilized in pharmaceutical research and development, particularly for treating neurological and brain-related diseases such as Alzheimer's and Parkinson's. This compound has potential to inhibit enzymes or biological targets involved in the pathological processes of these diseases. Additionally, JND3229 is being studied for its role in improving memory and learning through specific mechanisms of action. Researchers are testing its efficacy and safety in animal and cell models to evaluate its feasibility as a future therapeutic drug.